ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

DEBORAH PEABODY M.D.

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,499Medicare Part D Prescriptions Filled, Including Refills

Rank: 58 out of 546

$452K Total Retail Price of All Prescriptions

Rank: 73 out of 546

278 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 278 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

13% of this provider’s 278 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 5,131 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
FUROSEMIDE 328 279 1 5
HYDROCODONE-ACETAMINOPHEN 248 95 S3 2 8
OXYCODONE HCL 242 53 S2 3 15
METOPROLOL TARTRATE 212 194 4 6
LEVOTHYROXINE SODIUM 209 138 5 3
WARFARIN SODIUM 197 108 6 13
LISINOPRIL 192 182 7 1
PANTOPRAZOLE SODIUM 165 113 8 18
ZOLPIDEM TARTRATE 146 66 9 26
OMEPRAZOLE 137 114 10 4
AMLODIPINE BESYLATE 136 129 11 9
SIMVASTATIN 130 112 12 2
SERTRALINE HCL 121 79 13 14
TRAMADOL HCL 109 62 14 19
CITALOPRAM HBR 105 98 15 21
FENTANYL 95 82 S2 16 50
ATENOLOL 94 76 17 12
AZITHROMYCIN 87 56 18 55
GABAPENTIN 72 35 19 16
DIGOXIN 69 66 20 62
RANITIDINE HCL 67 38 21 23
METFORMIN HCL 67 50 21 10
METOPROLOL SUCCINATE 67 62 21 17
CYCLOBENZAPRINE HCL 67 13 R 21 34
PREDNISONE 65 53 25 29
GENERLAC 63 58 26 135
NEXIUM 60 46 27 52
BACLOFEN 59 27 28 86
FLUOXETINE HCL 51 19 29 39
OXYCODONE-ACETAMINOPHEN 51 0 S2 29 54
KLOR-CON M20 51 49 29 57
SPIRIVA 51 51 29 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.